[HTML][HTML] The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review
The global epidemiology of nonalcoholic fatty liver disease... : Hepatology The global
epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) …
epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) …
Global epidemiology of cirrhosis—aetiology, trends and predictions
Cirrhosis is an important cause of morbidity and mortality in people with chronic liver
disease worldwide. In 2019, cirrhosis was associated with 2.4% of global deaths. Owing to …
disease worldwide. In 2019, cirrhosis was associated with 2.4% of global deaths. Owing to …
[HTML][HTML] The global burden of metabolic disease: Data from 2000 to 2019
Global estimates of prevalence, deaths, and disability-adjusted life years (DALYs) from the
Global Burden of Diseases, Injuries, and Risk Factors Study 2019 were examined for …
Global Burden of Diseases, Injuries, and Risk Factors Study 2019 were examined for …
American Association of Clinical Endocrinology clinical practice guideline for the diagnosis and management of nonalcoholic fatty liver disease in primary care and …
K Cusi, S Isaacs, D Barb, R Basu, S Caprio… - Endocrine Practice, 2022 - Elsevier
Objective To provide evidence-based recommendations regarding the diagnosis and
management of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis …
management of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis …
[HTML][HTML] Changing epidemiology, global trends and implications for outcomes of NAFLD
Non-alcoholic fatty liver disease (NAFLD) has rapidly become the most common liver
disease globally and is currently estimated to affect 38% of the global population. Only a …
disease globally and is currently estimated to affect 38% of the global population. Only a …
Hepatocellular Carcinoma in Non-alcoholic Fatty Liver Disease: Emerging Burden
S Batool, K Morton Cuthrell, N Tzenios… - … Research Journal of …, 2022 - publish7promo.com
Liver is the largest solid organ in the body that performs over 100 functions. It removes the
toxins and waste products from the blood stream, maintains healthy blood sugar levels …
toxins and waste products from the blood stream, maintains healthy blood sugar levels …
Changing epidemiology of hepatocellular carcinoma in Asia
C Zhang, Y Cheng, S Zhang, J Fan, Q Gao - Liver International, 2022 - Wiley Online Library
Liver cancer is the fifth most common cancer and the second leading cause of malignant
death in Asia, and Asia reports 72.5% of the world's cases in 2020. As the most common …
death in Asia, and Asia reports 72.5% of the world's cases in 2020. As the most common …
Global incidence of non-alcoholic fatty liver disease: A systematic review and meta-analysis of 63 studies and 1,201,807 persons
MH Le, DM Le, TC Baez, Y Wu, T Ito, EY Lee… - Journal of …, 2023 - Elsevier
Background & Aims The prevalence of non-alcoholic fatty liver disease (NAFLD) is
increasing. We aimed to estimate the pooled global NAFLD incidence. Methods We …
increasing. We aimed to estimate the pooled global NAFLD incidence. Methods We …
Global burden of metabolic diseases, 1990–2021
H Zhang, XD Zhou, MD Shapiro, GYH Lip, H Tilg… - Metabolism, 2024 - Elsevier
Background Common metabolic diseases, such as type 2 diabetes mellitus (T2DM),
hypertension, obesity, hypercholesterolemia, and metabolic dysfunction-associated steatotic …
hypertension, obesity, hypercholesterolemia, and metabolic dysfunction-associated steatotic …
[HTML][HTML] Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach
Methods Prevalence data from 245 articles involving 2,699,627 persons were used with a
hierarchical Bayesian approach to forecast the prevalence of NAFLD through 2040 …
hierarchical Bayesian approach to forecast the prevalence of NAFLD through 2040 …